{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["GO Isoforms over19 ShinyGO"],"not_rendered":{"external_links":1,"defined_names":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"GO Isoforms over19 ShinyGO","index":0,"n_rows":47,"n_cols":7,"rows_kept":47,"merged":[[3,1,3,6],[5,2,5,5],[12,2,12,5],[22,2,22,5],[46,1,46,6]],"flags":["formulas_cached_only"]}
[]
[]
[]
[null,"Supplementary Table 7. \n Gene Ontology results for differential mRNA isoform expression patterns in the adult age group according to ShinyGO. "]
[]
[null,null,"GO Biological Process"]
[null,"Enrichment FDR","nGenes","Pathway Genes","Fold Enrichment","Pathways (click for details)","Genes"]
[{"$nulls":5},"none"]
[]
[]
[]
[]
[null,null,"GO Cellular Component"]
[null,"Enrichment FDR","nGenes","Pathway Genes","Fold Enrichment","Pathways (click for details)","Genes"]
[{"$nulls":5},"none"]
{"$rows_empty":7}
[null,null,"GO Molecular Function"]
[null,"Enrichment FDR","nGenes","Pathway Genes","Fold Enrichment","Pathways (click for details)","Genes"]
[null,0.0319125603460245,2,161,17.6987577639752,"Peptide receptor activity "," EDNRB  FPR1"]
[null,0.0319125603460245,3,335,12.7589552238806,"G protein-coupled receptor binding "," EDNRB  GHRL  FPR1"]
[null,0.0319125603460245,1,4,356.1875,"Carnitine O-palmitoyltransferase activity "," CPT1A"]
[null,0.0319125603460245,1,10,142.475,"Guanosine-diphosphatase activity "," CANT1"]
[null,0.0319125603460245,1,5,284.95,"Superoxide dismutase activity "," SOD3"]
[null,0.0319125603460245,1,4,356.1875,"N-formyl peptide receptor activity "," FPR1"]
[null,0.0319125603460245,1,4,356.1875,"Scavenger receptor binding "," FPR1"]
[null,0.0319125603460245,2,184,15.4864130434783,"Heparin binding "," SOD3  RPL29"]
[null,0.0319125603460245,1,4,356.1875,"Ribonuclease inhibitor activity "," RNH1"]
[null,0.0319125603460245,2,157,18.1496815286624,"G protein-coupled peptide receptor activity "," EDNRB  FPR1"]
[null,0.0319125603460245,1,8,178.09375,"Microtubule-severing ATPase activity "," FIGNL1"]
[null,0.0319125603460245,1,6,237.458333333333,"Carnitine O-acyltransferase activity "," CPT1A"]
[null,0.0319125603460245,1,5,284.95,"Oxidoreductase activity, acting on superoxide radicals as acceptor "," SOD3"]
[null,0.0319125603460245,1,8,178.09375,"Angiotensin receptor binding "," EDNRB"]
[null,0.0319125603460245,1,7,203.535714285714,"Type 1 angiotensin receptor binding "," EDNRB"]
[null,0.0319125603460245,1,10,142.475,"Uridine-diphosphatase activity "," CANT1"]
[null,0.0319125603460245,1,10,142.475,"RAGE receptor binding "," FPR1"]
[null,0.0319125603460245,1,10,142.475,"Glycogen binding "," PPP1R3E"]
[null,0.0323202475861013,1,11,129.522727272727,"Complement receptor activity "," FPR1"]
[null,0.041919184366082,1,15,94.9833333333333,"Nucleoside-diphosphatase activity "," CANT1"]
[]
[]
[null,"Column name and Description\n\nEnrichment FDR: Adjusted p-value indicating statistical significance of enrichment. \nnGenes: Number of genes in a pathway that overlap with the list of significant genes. \nPathway Genes: Total number of genes in a pathway. \nFold Enrichment: Magnitude of enrichment; higher values indicate stronger enrichment. \nPathway: Gene Ontology term. \nGenes: Names of genes in a pathway overlapping with the list of significant genes. \n"]